Clinical Trial Update: Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial evaluating allogeneic mesenchymal stem cells for critical limb ischemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: UNKNOWN